10x Genomics Blog Nov 7, 2025 Barclays Maintains 10x Genomics (TXG) Overweight Recommendation - Nasdaq #Overweight Recommendation #Barclays Maintains
Illumina Nov 1, 2025 Barclays Maintains Illumina (ILMN) Underweight Recommendation - Nasdaq #Maintains Illumina #Underweight Recommendation